Related Experiment Video

Updated: Feb 1, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

839

STAT1 inhibits STAT3 activation in esophageal squamous cell carcinoma

Zhaoyong Liu1, Ying Zhang2, Yelong Chen1

  • 1Department of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China, wanghu0754@163.com.

Cancer Management and Research
|December 18, 2018
PubMed
Abstract

Insights

Signal transducer and activator of transcription (STAT) 1 suppresses STAT3 activity in esophageal cancer. STAT1 and STAT3 show an inverse relationship, suggesting STAT3 downregulation or STAT1 upregulation as potential cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Signal transducer and activator of transcription (STAT) 1 acts as a tumor suppressor, while STAT3 is an oncogene.
  • The intricate cross-regulation between STAT1 and STAT3 in cancer remains incompletely understood.

Purpose of the Study:

  • To investigate the cross-regulation between STAT1 and STAT3 in esophageal squamous cell carcinoma (ESCC).
  • To elucidate the molecular mechanisms underlying STAT1-STAT3 interactions in cancer development.

Main Methods:

  • Co-immunoprecipitation (co-IP) to detect STAT1-STAT3 binding.
  • Luciferase reporter assays to measure transcription activity.
  • Immunohistochemistry to assess STAT1 and STAT3 expression in ESCC tissues.

Main Results:

  • STAT1 was found to attenuate STAT3 activity, reducing its transcription and DNA binding capabilities.
  • STAT3 downregulation led to increased phosphorylation and transcriptional activation of STAT1.
  • A negative correlation was observed between STAT1 and STAT3 expression levels in ESCC cases.

Conclusions:

  • This study demonstrates a significant cross-regulation between STAT1 and STAT3 in ESCC.
  • Targeting STAT3 downregulation or STAT1 accumulation presents a potential therapeutic strategy for ESCC treatment.
Keywords:
STAT1STAT3esophageal squamous cell carcinomatranscription activity

More Related Videos

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

4.1K
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.7K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.5K
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
597
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
870
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.4K